Clinical studies

Modern Multidisciplinary Medical Research Center

For Patients and Volunteers

Clinical Trials

Conducting Clinical Trials

Phase I and Bioequivalence Clinical TrialsCerta Clinic offers a range of capabilities and advantages to ensure the proper and high-quality conduct of Phase I and bioequivalence studies:

Purpose-built and well-organized internal infrastructure
Full spectrum of necessary equipment
Experienced, specially trained team of physicians and nurses
Standardized blood collection procedures for volunteers
Streamlined logistics for biological samples from collection to plasma freezing
Specialized nutritional arrangements for volunteers in accordance with protocol requirements
Availability of an intensive care unit and anesthesiologists
Ability to rapidly organize new (exclusive) processes, procedures, or equipment procurement in accordance with clinical trial protocols

Clinical Trials at Certa ClinicOur Clinical Center conducts Phase II–III trials of new drugs and diagnostic methods in the following areas:

Therapy
Clinical Pharmacology
Cardiology
Neurology
Endocrinology
Gastroenterology
Dermatology

Phase I Clinical TrialsPhase I trials represent the first experience of administering a new investigational drug to humans. They are most often conducted in healthy volunteers. Phase I studies begin with assessing the safety and pharmacokinetics of a single dose, based on preclinical data from biological models. These studies provide preliminary information on drug tolerability, safety, and initial pharmacokinetics and pharmacodynamics in humans.
Phase I studies typically evaluate:

Safety, tolerability, pharmacokinetics, and pharmacodynamics of a single dose, including determination of the maximum tolerated dose
Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses
Bioavailability (absorption) of the investigational drug in humans
Pharmacokinetics and pharmacodynamics of single and multiple doses via different routes of administration
Drug metabolism and influence of body weight
Effects of age, sex, food, liver and kidney function on pharmacokinetics and pharmacodynamics
Drug-drug interactions
Key Features of Phase I Trials:Relatively small volunteer groups, usually fewer than 100 participants
Conducted in a single specialized clinic with proper infrastructure, equipment, and trained personnel
Study duration ranges from several days to several weeks
Volunteers are under 24-hour medical supervision, with all procedures carefully standardized
Advantages of Certa Clinic for Phase I Trials:Purpose-built infrastructure compliant with international standards for Phase I studies
Required equipment, including resuscitation equipment
Experienced, specially trained team of physicians and nurses
Standardized blood collection procedures for volunteers
Streamlined logistics for biological samples from collection to plasma freezing
Specialized high-quality nutrition for volunteers in accordance with the study protocol
Availability of intensive care unit and anesthesiologists
Ability to rapidly implement new procedures or procure equipment per study protocol
Capability for rapid volunteer recruitment

Completed Projects in 2025

Completed Projects in 2024

Completed Projects in 2023